biotech news today glp-1 This is working on a pill that could be better than the Wegovy version Market Overview: GLP-1 Agonists and

A policyholder vote is, in the most literal sense, the only mechanism the owners have to consent to what happens to what they own

XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer

By integrating local action with overarching coordination, ASSET illustrates a paradigm shift towards a place-based circular economy

This growth was propelled by significant regulatory approvals, including the FDAs endorsement of Tagrisso combined with chemotherapy for first-line treatment of EGFR -mutated non-small cell lung cancer (NSCLC) and its use in unresectable stage III NSCLC following chemoradiation therapy